Argument for Legalising Cannabis After Vape Substance Concerns
This article discusses legalizing cannabis clinical implications in light of risks from synthetic cannabinoids found in some vape products. Legalization could enhance patient safety by regulating product quality and reducing harmful alternatives.…
Endocannabinoid Biology in Health & Disease | Nephi Stella | Episode 305 – Mind & Matter
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Study Reveals CBDA’s Potential Neuroprotective Effects and Brain Benefits
This CBDA neuroprotective effects study highlights promising evidence that CBDA, a cannabis compound, may reduce neuroinflammation and improve brain insulin signaling. These findings suggest potential benefits for neurological conditions, though further…
New UMSOP Graduate Certificate in Medical Cannabis Clinical Science
The new medical cannabis clinical education graduate certificate at UMSOP equips healthcare professionals with evidence-based knowledge to improve patient care. This program enhances understanding of cannabis therapy, enabling informed clinical…
Comparative efficacy of non-pharmacological interventions for individuals with cannabis use disorder
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Daily Cannabis News Brief for August 21, 2026
This daily cannabis news digest August 2026 highlights emerging clinical updates on CBDA's potential to reduce neuroinflammation and improve brain insulin signaling. These findings could impact neurological condition management. Stay informed with the…
Canada’s Health Ministry Announces $24M Cannabis Research Funding
Canada's health ministry has announced a $24 million cannabis clinical research funding initiative to expand evidence on cannabinoids such as THC and CBD. This investment aims to enhance clinical understanding and guide patient care. The funding supports…
Study Finds CBDA May Reduce Neuroinflammation and Improve Brain Insulin Signaling
Recent research highlights the cbda therapeutic potential neuroinflammation benefits, showing CBDA's ability to reduce brain inflammation and improve insulin signaling. These findings suggest promising applications for neurological and metabolic…
Navigating Federal Cannabis Home Cultivation Rights and Rescheduling
This article explores federal cannabis home cultivation rights amid rescheduling efforts, highlighting implications for medical research and patient care. Understanding these changes is vital for clinicians and patients navigating evolving cannabis…